{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:58:52Z","timestamp":1761821932791,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012513","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Cardiovasculares","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00232"],"award-info":[{"award-number":["PI16\/00232"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.rec.2019.06.014","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:15:40Z","timestamp":1573060540000},"page":"376-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prior adherence to recommended lipid control targets in patients admitted for acute coronary syndrome"],"prefix":"10.1016","volume":"73","author":[{"given":"Laia","family":"Mil\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Barrab\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa-Maria","family":"Lid\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Sambola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Ba\u00f1eras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Oristrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Rafecas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Garc\u00eda-Dorado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2019.06.014_bib0180","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2019.06.014_bib0185","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2019.06.014_bib0190","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1157\/13124991","article-title":"MASCARA (Manejo del S\u00edndrome Coronario Agudo. Registro Actualizado) Study. General Findings","volume":"61","author":"Ferreira-Gonz\u00e1lez","year":"2008","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.recesp.2014.03.010","article-title":"Prognosis and management of acute coronary syndrome in Spain in 2012: the DIOCLES study","volume":"68","author":"Barrab\u00e9s","year":"2015","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0200","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2019.06.014_bib0205","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2017.03.535","article-title":"On the stability of stable coronary artery disease","volume":"69","author":"Barrab\u00e9s","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0210","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.recesp.2017.05.028","article-title":"High-intensity statin treatments in clinically stable patients on aspirin monotherapy 12 months after drug-eluting stent implantation: a randomized study","volume":"71","author":"Im","year":"2018","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0215","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2019.06.014_bib0220","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2019.06.014_bib0225","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2019.06.014_bib0230","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2019.06.014_bib0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2008.08.010","article-title":"Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines","volume":"157","author":"Sachdeva","year":"2009","journal-title":"Am Heart J."},{"key":"10.1016\/j.rec.2019.06.014_bib0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1741826711400545","article-title":"Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada","volume":"19","author":"Gitt","year":"2012","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0245","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/1741826710397100","article-title":"Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey","volume":"19","author":"Park","year":"2012","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0250","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0255","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/2047487316647827","article-title":"Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries","volume":"23","author":"Zhao","year":"2016","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0260","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2016.09.004","article-title":"Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients","volume":"255","author":"Gitt","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2019.06.014_bib0265","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.recesp.2016.10.012","article-title":"Attainment of LDL cholesterol treatment goals in children and adolescents with familial hypercholesterolemia. The SAFEHEART Follow-up Registry","volume":"70","author":"Saltijeral","year":"2017","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.atherosclerosis.2018.02.024","article-title":"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: insights from Italian general practice","volume":"271","author":"Arca","year":"2018","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2019.06.014_bib0275","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2017.11.020","article-title":"Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: real-world evidence from Germany","volume":"268","author":"M\u00e4rz","year":"2018","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2019.06.014_bib0280","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/eurheartj\/ehi079","article-title":"The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice","volume":"26","author":"Flynn","year":"2005","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2019.06.014_bib0285","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem."},{"key":"10.1016\/j.rec.2019.06.014_bib0290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.recesp.2018.05.009","article-title":"Hospital mortality in 415 798 AMI patients: 4 years earlier in the Canary Islands than in the rest of Spain","volume":"72","author":"Mate Redondo","year":"2019","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0295","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.recesp.2010.10.030","article-title":"Prevalencia y caracter\u00edsticas de la dislipemia en pacientes en prevenci\u00f3n primaria y secundaria tratados con estatinas en Espa\u00f1a. Estudio DYSIS-Espa\u00f1a","volume":"64","author":"Gonz\u00e1lez-Juanatey","year":"2011","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0300","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.recesp.2016.02.013","article-title":"Degree of Lipid Control in Patients With Coronary Heart Disease and Measures Adopted by Physicians","volume":"69","author":"Galve","year":"2016","journal-title":"REPAR Study. Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2013.02.049","article-title":"Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease","volume":"112","author":"Battes","year":"2013","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0310","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.08.013","article-title":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II","volume":"266","author":"Gitt","year":"2017","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2019.06.014_bib0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1570161115666170621120529","article-title":"Patients with acute coronary syndrome are at high risk prior to the event and lipid management is underachieved pre- and post- hospitalization","volume":"16","author":"Vlachopoulos","year":"2018","journal-title":"Curr Vasc Pharmacol."},{"key":"10.1016\/j.rec.2019.06.014_bib0320","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART Registry follow-up","volume":"67","author":"Perez de Isla","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0325","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.recesp.2015.08.010","article-title":"Trends in risk factors and treatments in patients with stable ischemic heart disease seen at cardiology clinics between 2006 and 2014","volume":"69","author":"Cordero","year":"2016","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1477-7525-8-137","article-title":"The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial","volume":"8","author":"Mu\u00f1iz","year":"2010","journal-title":"Health Qual Life Outcomes."},{"key":"10.1016\/j.rec.2019.06.014_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.recesp.2017.03.019","article-title":"Efficacy of a combined strategy to improve low-density lipoprotein cholesterol control among patients with hypercholesterolemia: a randomized clinical trial","volume":"71","author":"P\u00e1rraga-Mart\u00ednez","year":"2018","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.recesp.2017.03.027","article-title":"Persistence with statins in primary prevention of cardiovascular disease: findings from a cohort of Spanish workers","volume":"71","author":"Malo","year":"2018","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0345","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0735-1097(93)90213-K","article-title":"Myocardial injury: the acute phase response and lipoprotein metabolism","volume":"22","author":"Rosenson","year":"1993","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2019.06.014_bib0350","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacc.2007.11.075","article-title":"Lipid levels after acute coronary syndromes","volume":"51","author":"Pitt","year":"2008","journal-title":"J Am Coll Cardiol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585719302932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585719302932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:57:17Z","timestamp":1761821837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585719302932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1885585719302932"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2019.06.014","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prior adherence to recommended lipid control targets in patients admitted for acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2019.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2019.06.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}